A5070253720- Heart Failure Treatment and Management
- Cardiac Health and Mental Health
- Cardiovascular Function and Risk Factors
- Health Systems, Economic Evaluations, Quality of Life
- Chronic Disease Management Strategies
- Nursing Roles and Practices
- Pharmaceutical Practices and Patient Outcomes
- Primary Care and Health Outcomes
- Cardiac Arrest and Resuscitation
- Healthcare Policy and Management
- Medication Adherence and Compliance
- Cardiac, Anesthesia and Surgical Outcomes
- Emergency and Acute Care Studies
- Geriatric Care and Nursing Homes
- Global Health Workforce Issues
- Cardiac pacing and defibrillation studies
- Cardiac Valve Diseases and Treatments
- Antibiotic Use and Resistance
- Diet and metabolism studies
- Diabetic Foot Ulcer Assessment and Management
- Diabetes Management and Education
- Cardiac Imaging and Diagnostics
- Traumatic Brain Injury Research
- Clinical practice guidelines implementation
- Physical Activity and Health
Deakin University
2016-2025
Austin Health
2016-2025
Monash Health
2024-2025
Monash University
2011-2024
Austin Hospital
1993-2024
ORCID
2023
Heidelberg Repatriation Hospital
2022
Driscoll Children's Hospital
2009-2020
Royal Prince Alfred Hospital
2019
Respiratory Clinical Trials
2019
Heart failure is a clinical syndrome that affects >6.5 million Americans, with an estimated 550 000 new cases diagnosed each year. The complexity of heart management compounded by the number patients who experience adverse downstream effects social determinants health (SDOH). These are less able to access care and more likely poor outcomes over time. Many face additional challenges associated cost complex, chronic illness must make difficult decisions about their own health, particularly...
Managing post‐discharge care at home: an analysis of patients’ and their carers’ perceptions information received during stay in hospital This small‐scale study carried out a Melbourne metropolitan explored information, adequacy utilization concerning from health professionals hospital. The research design consisted two stages. Stage one involved qualitative approach using focused interviews five pairs patients carers, 2 weeks after discharge Five main themes emerged the content interview...
Chronic heart failure (CHF) is a progressive and debilitating disease with broad symptom profile, intermittently marked by periods of acute decompensation. CHF patients are encouraged to self-manage their illness, such as adhering medical regimens monitoring symptoms, optimise health outcomes quality life. In so doing, asked collaborate service providers regard care. However, generally do not well, even specialist support. Moreover, self-management interventions yet demonstrate morbidity or...
Summary Background Heart failure ( HF ) remains a condition with high morbidity and mortality. We tested telephone support strategy to reduce major events in rural remote Australians , who have limited healthcare access. Telephone comprised an interactive telecommunication software tool (TeleWatch) follow‐up by trained cardiac nurses. Methods Patients general practice GP diagnosis of were randomized usual care UC or intervention + I using cluster design involving 143 s throughout Australia....
The National Heart Foundation of Australia assembled an expert panel to provide guidance on policy and system changes improve the quality care for people with chronic heart failure (CHF). recommendations have potential reduce emergency presentations, hospitalisations premature death among patients CHF. Best-practice management CHF involves evidence-based, multidisciplinary, patient-centred care, which leads better health outcomes. A model is required achieve this. Although programs exist,...
This feature article for the thematic series on congestive heart failure (CHF) readmissions aims to outline important gaps in guidelines patients with multiple comorbidities and elderly. Congestive diagnosis manifests as a 3-phase journey between hospital community, during acute, chronic stable, end-of-life (palliative) phases. requires variable intensities combination of multidisciplinary care within tertiary or ambulatory from outpatients primary health services, general community....
Heart failure (HF) is a clinical syndrome that secondary to an abnormality of cardiac structure or function. These practice guidelines focus on the diagnosis and management HF with recommendations have been graded strength evidence likely absolute benefit versus harm. Additional considerations are presented as points. Main recommendations: Blood pressure lipid lowering decrease risk developing HF. Sodium-glucose cotransporter 2 inhibitors hospitalisation in patients type diabetes...
Objective: To compare the location and accessibility of current Australian chronic heart failure (CHF) management programs general practice services with probable distribution population CHF. Design setting: Data on prevalence CHF throughout Australia, locations from 1 January 2004 to 31 December 2005 were analysed using geographic information systems (GIS) technology. Outcome measures: Distance populations services. Results: The highest (20.3–79.8 per 1000 population) occurred in areas high...
Beta-adrenergic blockade has been shown to improve left ventricular function, reduce hospital admissions and survival in chronic heart failure with reduced ejection fraction (HFrEF), mortality reduction starting early after beta-adrenergic receptor blocker initiation being dose-related. The aim of this pilot study was determine the effectiveness a nurse-led titration clinic improving time required for patients reach optimal doses blocking agents. We conducted prospective randomized...
Identifying patients at high risk of falling is crucial in implementing effective fall prevention programs. While the integration information systems becoming more widespread healthcare industry, it poses a significant challenge analysing vast amounts data to identify factors that could enhance patient safety.
A series of experiments has been carried out to investigate the adjuvant properties amino acid L-tyrosine in laboratory animals. Adsorption various allergenic materials was found enhance induction IgG antibodies, but no unusual propensity stimulate IgE antibody or delayed hypersensitivity observed. Administration at a site remote from allergen not augment production. This, together with evidence reduced bioavailability tyrosine-adsorbed allergen, suggested that activity observed resulted...